The invention relates to compounds useful as inhibitors of NO production, especially inhibitors of the inducible NO synthase iNOS expressed by microglia and macrophages. The invention also relates to pharmaceutical compositions comprising these compounds and to therapeutic uses of these compounds, especially in the prophylaxis or treatment of conditions characterized by excess NO production, such as ischemic stroke and retinopathies.
本发明涉及一种化合物,其可用作NO产生的
抑制剂,特别是可抑制由微胶质细胞和巨噬细胞表达的诱导型NO合酶iNOS的
抑制剂。本发明还涉及含有这些化合物的药物组合物,以及这些化合物的治疗用途,特别是在预防或治疗由过量NO产生所表征的疾病中,如缺血性卒中和视网膜病。